Super NAD+
The Blend They Can't Match
Three synergistic compounds. One lyophilized vial. A 3x/week SubQ protocol engineered around actual biochemistry — not clinic marketing.
Why Everything Else Is Getting It Wrong
The NAD+ supplement market is built on three compounding misconceptions. Here's what they're not telling you.
❌ Injecting NAD+ Directly Doesn't Work
NAD+ is too large and too charged to cross cell membranes. Injected NAD+ is degraded extracellularly to nicotinamide within minutes. IV NAD+ clinics charging $400–800 per session are selling you a nicotinamide flush — not NAD+ delivery. The "energy and clarity" you feel is a niacin surge, not cellular NAD+ restoration.
❌ Oral NMN Wastes 70% of Every Dose
Oral NMN faces gut enzyme degradation, hepatic first-pass metabolism, and intestinal conversion to NR and nicotinamide before it ever reaches your tissues. Studies confirm only 25–30% bioavailability. You're paying for 500mg and getting 125mg. Every single day.
❌ Nobody Addresses the Methyl Drain
High-dose NMN supplementation activates sirtuins, which generates nicotinamide as a byproduct. Clearing that nicotinamide consumes SAM — your body's universal methyl donor. Sustained NMN without methyl support depletes methylation capacity, raises homocysteine, and undermines the very longevity pathways you're trying to activate.
Three Compounds. One Vial. Complete Stack.
75mg × 12 injections
25mg × 12 injections
1mg × 12 injections
Draw 0.42mL — ~42 units on insulin syringe
3x/week (Mon / Wed / Fri)
- NMN — The WorkhorseThe most bioavailable SubQ NAD+ precursor. Enters cells directly via the Slc12a8 transporter — no extracellular degradation, no conversion losses. 100mg SubQ delivers what 300–400mg oral cannot.
- NAD+ — The Second WaveDegrades extracellularly to NMN via CD38/CD73 after injection, creating a delayed second bolus of NMN in the interstitial fluid. Additive effect, not redundant. Acts as a slow-release NMN depot alongside the direct NMN hit.
- Methylcobalamin — The ProtectorThe only injectable methyl donor that directly replenishes SAM depleted by NMN metabolism. Injectable B12 is nearly 100% bioavailable vs ~1% oral. Keeps homocysteine in check and protects the methylation pathways NMN activates.
- Pharma-Grade LyophilizedFreeze-dried for maximum stability. No degradation during storage. 10mL amber vial — amber glass protects B12 from light. One reconstitution, 12 injections (3x/week). 10mL amber vial.
Why SubQ NMN Outperforms Everything Else
Every claim we make is anchored to primary literature. Here's the mechanism behind each compound.
NAD+ biosynthesis requires NAMPT — an enzyme that declines significantly with age. NMN bypasses the upstream steps that NAMPT controls, entering the pathway downstream and restoring NAD+ even when NAMPT activity has collapsed in aged tissues.
NMN enters cells via the Slc12a8 transporter confirmed in a 2019 Nature Metabolism study. This is a direct transport mechanism — NMN doesn't need to be converted extracellularly before cellular uptake. SubQ injection delivers intact NMN directly to this transporter.
NAD+ is the substrate for sirtuins (SIRT1–7) — the longevity enzymes that regulate DNA repair, mitochondrial biogenesis, inflammation, and metabolic efficiency. You can't activate sirtuins without NAD+. Restoring NAD+ to youthful levels is the mechanism, not the endpoint.
CD38 is an enzyme that degrades NAD+ and rises with age and inflammation. It's the primary driver of age-related NAD+ decline. A 2016 Cell Metabolism study showed CD38 knockout mice maintain elevated NAD+ with age. Oral apigenin (50mg daily) is the practical CD38 inhibitor that makes every injection go further.
Sirtuin activation generates nicotinamide. Clearing nicotinamide via NNMT consumes SAM — your body's methyl donor. Without replenishment, sustained NMN supplementation can deplete methylation capacity over time, raise homocysteine, and undermine epigenetic regulation. Methylcobalamin in the vial solves this directly.
Oral NMN bioavailability is estimated at 25–30% due to gut enzyme degradation and hepatic first-pass metabolism. SubQ bypasses both. A 75mg SubQ dose delivers what 250–300mg oral cannot. Human studies at 1g/day oral showed 1.7× blood NAD+ elevation — SubQ achieves comparable elevation at a fraction of the dose.
The Bioavailability Gap Is Not Small
This isn't a marginal difference. Oral NMN loses the majority of every dose before it reaches your tissues.
- Gut enzymes convert NMN to NR and nicotinamide before absorption
- Portal circulation delivers straight to liver — first-pass metabolism consumes a significant fraction
- ~25–30% estimated bioavailability — you're paying for 500mg, getting ~130mg
- Absorption varies with food, gut motility, and individual enzyme expression
- Inconsistent dose response — you never know what actually reached your tissues
- Gut microbiome consumes some NMN before absorption
- Bypasses gut entirely — no enzymatic degradation before systemic circulation
- No hepatic first-pass — full dose enters systemic circulation intact
- ~100% bioavailability — 75mg injected is 75mg delivered
- Consistent absorption shot to shot regardless of meals or GI status
- Plasma peak in 15–30 minutes vs 1–2 hours oral
- 75mg SubQ ≈ 250–300mg oral — at a fraction of the cost per effective dose
How the Blend Works After Injection
NMN and NAD+ in the same injection aren't redundant — they hit at different times through different mechanisms.
Injected NMN enters systemic circulation immediately. Slc12a8 transporters on cell surfaces begin direct cellular uptake. Intracellular NMN is phosphorylated to NAD+ via NMNAT — no rate-limiting steps. Tissue NAD+ begins rising within 30 minutes.
The injected NAD+ component hits pH 7.4 interstitial fluid and CD38/CD73 begin cleaving it extracellularly to NMN. This free NMN joins the existing pool in the interstitial fluid. A second, smaller NMN bolus enters the pathway — extending the delivery window.
Tissue NAD+ remains elevated for 4–8 hours post-injection. Daily dosing maintains consistently elevated intracellular NAD+ — restoring the substrate sirtuins need to operate. Methylcobalamin replenishes SAM continuously throughout the cycle.
Why Every NMN Product Without B12 Is Incomplete
This is the mechanism most supplement companies either don't understand or don't want to explain.
The Methyl Drain Cascade
Methylcobalamin isn't a nice-to-have addition. It's the compound that makes sustained NMN supplementation safe and complete. Here's what injectable B12 does that oral cannot:
- ~100% bioavailability — oral B12 absorption is limited to ~1% at therapeutic doses due to intrinsic factor saturation. Injectable bypasses this entirely.
- Immediate systemic availability — no gut absorption variability, no intrinsic factor dependence, no gastric acid degradation.
- Direct methyl donor — methylcobalamin (not cyanocobalamin) provides the methyl group directly to the methylation cycle without additional conversion steps.
- Homocysteine clearance — B12 is the cofactor for methionine synthase, the enzyme that converts homocysteine back to methionine. Elevated homocysteine is an independent cardiovascular and neurological risk factor.
- Visual QC indicator — the pink/red color of reconstituted Super NAD+ is the methylcobalamin. If the solution is colorless after reconstitution, the B12 has degraded and the vial should be discarded. Color = quality confirmation built in.
Super NAD+ vs. The Alternatives
| IV NAD+ Clinics | Oral NMN Capsules | Super NAD+ SubQ | |
|---|---|---|---|
| Mechanism | NAD+ degraded to NAM before cell entry | NMN degraded in gut, first-pass loss | Direct NMN cellular uptake via Slc12a8 |
| Bioavailability | Low — most NAD+ never enters cells | ~25–30% of dose reaches tissues | ~100% — full dose enters circulation |
| Methyl Support | ✗ None | ✗ None | ✓ Methylcobalamin included |
| Consistency | Variable — session to session | Variable — food, gut motility, enzymes | Consistent — same dose every injection |
| Cost per month | $300–800+ per session | $30–80/month for quality brands | Fraction of clinic cost, superior delivery |
| Lyophilized stability | ✗ IV bag, single use | ✗ N/A | ✓ 18–24 month shelf life frozen |
| Self-administrable | ✗ Clinic only | ✓ Yes | ✓ Simple SubQ — insulin syringe |
The Protocol At A Glance
Common Questions
That's the methylcobalamin (Methyl B12). It's completely normal and expected — in fact it's a quality indicator. At 2.4mg/mL the solution will appear nearly clear to very faint pink — this is normal and correct at this concentration. If the solution is visibly yellow or cloudy, discard.
SubQ injection with a standard U-100 insulin syringe. Draw 0.42mL (~42 units on the syringe). Common sites: abdomen (pinch an inch of fat, inject at 45°), outer thigh, or flank. Rotate sites. Inject 3x/week — Monday, Wednesday, Friday works well. 0.42mL is a comfortable SubQ volume.
Add 5mL of bacteriostatic water (BAC water, 0.9% benzyl alcohol) through the rubber stopper using a clean needle and syringe. Gently swirl — do not shake. The lyophilized cake dissolves in under 60 seconds. Store reconstituted vial at 2–8°C, protected from light, and use within 30 days (12 injections over ~4 weeks).
NAD+ injected alongside NMN creates a dual-wave delivery mechanism. While NMN is absorbed directly via the Slc12a8 transporter (Wave 1), the NAD+ degrades extracellularly to NMN via CD38/CD73 over the next 30–90 minutes (Wave 2), adding a second delayed bolus. The effect is modest (~10–15% additive) but the mechanism is real and the cost is negligible.
For maximum effect: oral apigenin 50–100mg daily (CD38 inhibitor — blocks the enzyme that degrades NAD+, making every injection go further) and trans-resveratrol 200–500mg with a fatty meal (SIRT1 activator — activates the enzymes that NAD+ feeds). These are oral and complementary — they hit completely different mechanisms than what's in the vial.
Freeze at −20°C, protected from light. The lyophilized cake is stable for 18–24 months properly stored. The amber vial provides light protection, but an opaque storage bag or box is ideal for freezer storage. Once reconstituted, refrigerate at 2–8°C and use within 30 days.
Ready to Do This Right?
Stop paying clinic prices for inferior delivery. Stop losing 70% of every oral dose. The complete protocol, explained without the marketing fluff.
View Full Protocol Guide →Disclaimer: This content is for informational and research purposes only and does not constitute medical advice. Consult a qualified healthcare provider before beginning any injection protocol. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
© 2025 Feel No Time · Evidence-Based Protocols